PRAMEL12 orchestrates spermiogenesis to ensure male fertility in mice

Knocking out a single gene in mice triggers complete male infertility by blocking the histone-to-protamine swap that compacts sperm DNA

Journal: The Journal of Biological Chemistry | Published: 2026-03-20 | Type: Journal Article | PMID: 41866036 Authors: Li Nana, Wang Xiao, Li Hong, Wang Zhengpin (Shandong Provincial Key Laboratory of Development and Regeneration, School of Life Sciences) Funding/COI: Funding not listed. Authors declare no conflicts of interest.

Summary

Mice lacking the PRAMEL12 gene are completely sterile — males produce almost no functional sperm, while females are unaffected. The culprit is a failure in spermiogenesis, the final maturation phase where round spermatids transform into spermatozoa. Specifically, PRAMEL12 appears necessary for the histone-to-protamine transition: the process by which sperm replace standard chromatin packaging with tightly compressed protamine-based packaging, and without it, sperm heads don't condense properly.

Claims

• Complete male infertility in Pramel12-null mice; zero offspring produced across all fertility trials
• Drastic reduction in sperm counts, severely impaired motility, and markedly increased morphological abnormalities in knockout males
• Elevated histone marks H3K4me3, H3K9me3, H3K27me3, H3K23ac and reduced H4K8ac in mature sperm of knockout males
• Increased retention of core histones H2A, H3, and H4 in mature sperm — indicating failed histone removal
• Impaired incorporation of transition proteins TNP1/TNP2 and protamine PRM2
• scRNA-Seq identified dysregulation of genes governing sperm chromatin condensation in knockout spermatids
• Proteomic profiling showed significant alterations in proteins for sperm structure, function, and manchette assembly
• By 12 months, knockout males show testicular atrophy and near-complete loss of meiotic and postmeiotic cells — a progressive, time-dependent deterioration

Study Quality

This is a rigorous mouse knockout study using CRISPR-Cas9 to delete the entire Pramel12 coding sequence, validated by Sanger sequencing, qRT-PCR, and in situ hybridization. The multi-omic approach — combining single-cell RNA-Seq, proteomics, and histochemistry — is appropriate for characterizing a novel gene's function and gives the findings more mechanistic grounding than histology alone. The cross-sectional design with two timepoints (4 months and 12 months) captures a progressive phenotype, though the authors themselves acknowledge that longitudinal tracking of the same cohort would strengthen causal inference about the timeline of decline.

The complete absence of functional PRAMEL12 is an extreme manipulation. Complete knockouts model the worst-case scenario; whether partial loss-of-function (as might occur in human hypomorphic variants) produces a milder or subtler phenotype remains untested. Translating findings from mouse spermiogenesis to human male infertility requires independent validation in human tissue or patient data, neither of which is provided here.

Red Flags

• Mouse model only — no human data, no patient cohort, no germline variant analysis in infertile men
• Funding source not disclosed, making it impossible to assess external pressures on the work
• Complete gene deletion is a maximally disruptive model; natural human variants would likely be partial
• No fertility rescue experiment (re-expressing PRAMEL12 in null mice) to confirm the phenotype is specifically attributable to PRAMEL12 loss rather than genomic disruption artifacts
• PRAME family members are cancer/testis antigens — their biology in cancer versus normal testis is not fully disentangled here

Strengths

• CRISPR knockout model rigorously validated at genomic, transcript, and protein levels
• Multi-omic approach (scRNA-Seq + proteomics + histochemistry) provides convergent mechanistic evidence
• Identifies a specific molecular defect — failed histone-to-protamine exchange — rather than just phenotypic sterility
• Progressive phenotype across two age cohorts adds biological depth
• Clearly situates PRAMEL12 within the broader PRAME family, distinguishing its postmeiotic role from the premeiotic roles of PRAMEF12 and PRAMEL1

Verdict

This is competent, well-characterized mouse genetics work that establishes PRAMEL12 as a genuine regulator of the histone-to-protamine transition in spermiogenesis — a process relevant to male infertility and a known but incompletely mapped pathway. The multi-omic design adds credibility beyond a purely morphological knockout study. The leap to clinical relevance is large: there is no human data, no infertile patient cohort, and no indication that PRAMEL12 variants are found in men with defective sperm chromatin compaction. Worth reading if you work on sperm chromatin biology or the PRAME gene family; not yet actionable for anyone else.